Commonwealth Coat of Arms of Australia

 

National Health (Pharmaceutical Benefits)

(Pharmacist Substitution of Medicines without

Prescription during Shortages) Amendment (No. 3) Determination 2023

I, Nikolai Tsyganov, as delegate of the Minister for Health and Aged Care, make the following determination.

Dated 1 May 2023

 

 

 

Nikolai Tsyganov

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health and Aged Care

 

1 Name...............................................1

2 Commencement.........................................1

3 Authority.............................................1

4 Schedules.............................................1

Schedule 1—Amendments 2

National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination 2021

 

 

  1.     This instrument is the National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Amendment (No. 3) Determination 2023.
  2.     This instrument may also be cited as PB 41 of 2023.
  1.     Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

 

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 May 2023

1 May 2023

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

  1.     Any information in column 3 of the table is not part of this instrument.

Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

  This instrument is made under subsection 89A(3) of the National Health Act 1953.

 Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

National Health (Pharmaceutical Benefits) (Pharmacist Substitution of

Medicines without Prescription during Shortages) Determination 2021

1  Subsection 5(8), after item 42 dealing with Phenoxymethylpenicillin

Insert:

43

Listed drug: Cefaclor

Form: Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL

Manner of administration: Oral

Brand: Ceclor

Listed drug: Cefaclor

Form: Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL

Manner of administration: Oral

Brand: Any of the following

  1.        Ceclor
  2.        Keflor
  3.        APO-Cefaclor
  4.        Aclor 250

44

Listed drug: Cefaclor

Form:  Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL

Manner of administration: Oral

Brand: Keflor

Listed drug: Cefaclor

Form: Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL

Manner of administration: Oral

Brand: Any of the following

  1.        Ceclor
  2.        Keflor
  3.        APO-Cefaclor
  4.        Aclor 250

45

Listed drug: Cefaclor 

Form: Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL

Manner of administration: Oral

Brand: Ceclor

Listed drug: Cefaclor 

Form: Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL

Brand: Any of the following:

         a) Ceclor

         b) Keflor

         c) Aclor 125

46

Listed drug: Cefaclor 

Form: Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL

Manner of administration: Oral

Brand: Keflor

Listed drug: Cefaclor

Form: Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL

Manner of administration: Oral

Brand: Any of the following:

         a) Ceclor

         b) Keflor

         c) Aclor 125